alexa Evaluation Of HLA-G And IL10 Expression Levels In HCV Infected Patients Receiving Combination Therapy
ISSN: 1948-5964

Journal of Antivirals & Antiretrovirals
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th World Congress on Virology
October 06-08, 2014 Hilton San Antonio Airport, TX, USA

Kiana Shahzamani
Accepted Abstracts: J Antivir Antiretrovir
DOI: 10.4172/1948-5964.S1.022
Hepatitis C disease is virus mediated infection causing major health problem worldwide. Conversions of immune surveillance play important roles in viral clearance. Immune modulating molecules such as HLA-G and IL-10 that shift immune response to T helper 2 (Th2) may play a role to inhibit response to combination therapy with IFN-α and Ribavirin. The aim of this study was to investigate the expression of HLA-G and IL-10 in HCV infected patients. In this study, HCV viral load and genotype were assessed using an in-house real-time RT-PCR assay. The expression levels of HLA-G and IL-10 were also evaluated by a developed real-time PCR method. Moreover, soluble HLA-G in both groups of patients (48 responder and non-responder) and 50 healthy individuals were determined by enzyme-linked immunosorbent assay (ELISA). According to obtained data, HCV genotype 1a was predominant in both responder and non-responder patients. Expression levels of HLA-G and IL-10 in non-responder group was significantly more that responder and control groups (P <0.001). Also, expression levels of HLA-G and IL-10 in non-responder at the beginning of treatment was remarkably higher in comparison with healthy individuals. After treatment, soluble HLA-G level was significantly increased in non-responders when compared to responders (P <0.001). These findings suggest that elevated expression level of HLA-G and IL-10 in HCV infected patients play an important role in response to combination therapy.
Kiana Shahzamani has completed her Ph.D at the age of 32 years from Tarbiat Modares University. She is scientific member of Lorestan University and research fellow in Digestive Disease research Institute (DDRI). She is also the director of reference lab in Health deputy of Lorestan University of Medical Science and the manager of talented organization in Lorestan Province. She has published more than 15 papers in reputed journals.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version